National Oxygen Share Price
Sector: Chemical Manufacturing
110.95 +0.35 (0.32%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
105
Today’s High
113
52 Week Low
94.95
52 Week High
165
Key Metrics
- Market Cap (In Cr) 56
- Beta 0.68
- Div. Yield (%) 0
- P/B -
- TTM P/E -
- Sector P/E 17.45
- Open Price 105
- Prev Close 110.6
National Oxygen Analysis
Price Analysis
-
1 Week5.79%
-
3 Months-3.41%
-
6 Month-12.15%
-
YTD-17.31%
-
1 Year-24.09%
Risk Meter
- 46% Low risk
- 46% Moderate risk
- 46% Balanced Risk
- 46% High risk
- 46% Extreme risk
National Oxygen News
Jhansi hospital fire kills 10 newborns: Modi, Adityanath announce ex-gratia
1 min read . 16 Nov 2024Watching YouTube is not adequate to perform aesthetic and hair transplant: NMC
2 min read . 27 Sep 2022National Oxygen Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 45.26
- Selling/ General/ Admin Expenses Total
- 3.38
- Depreciation/ Amortization
- 3.33
- Other Operating Expenses Total
- 10.55
- Total Operating Expense
- 47.35
- Operating Income
- -2.09
- Net Income Before Taxes
- -3.23
- Net Income
- -3.23
- Diluted Normalized EPS
- -6.41
- Period
- 2024
- Total Assets
- 34.11
- Total Liabilities
- 35.11
- Total Equity
- -1
- Tangible Book Valueper Share Common Eq
- -2.02
- Period
- 2024
- Cashfrom Operating Activities
- 0.97
- Cashfrom Investing Activities
- -3.69
- Cashfrom Financing Activities
- 1.07
- Net Changein Cash
- -1.66
- Period
- 2023
- Total Revenue
- 47.11
- Selling/ General/ Admin Expenses Total
- 3.72
- Depreciation/ Amortization
- 3.27
- Other Operating Expenses Total
- 9.22
- Total Operating Expense
- 46.7
- Operating Income
- 0.41
- Net Income Before Taxes
- -0.79
- Net Income
- -0.79
- Diluted Normalized EPS
- -1.65
- Period
- 2023
- Total Assets
- 34.91
- Total Liabilities
- 35.84
- Total Equity
- -0.93
- Tangible Book Valueper Share Common Eq
- -1.99
- Period
- 2023
- Cashfrom Operating Activities
- 2.23
- Cashfrom Investing Activities
- -0.62
- Cashfrom Financing Activities
- -5.93
- Net Changein Cash
- -4.32
- Period
- 2022
- Total Revenue
- 50.61
- Selling/ General/ Admin Expenses Total
- 3.9
- Depreciation/ Amortization
- 3.09
- Other Operating Expenses Total
- 5.78
- Total Operating Expense
- 42.17
- Operating Income
- 8.44
- Net Income Before Taxes
- 7.63
- Net Income
- 7.63
- Diluted Normalized EPS
- 13.6
- Period
- 2022
- Total Assets
- 39.8
- Total Liabilities
- 39.79
- Total Equity
- 0.02
- Tangible Book Valueper Share Common Eq
- -0.03
- Period
- 2022
- Cashfrom Operating Activities
- 11.6
- Cashfrom Investing Activities
- 0.4
- Cashfrom Financing Activities
- -6.58
- Net Changein Cash
- 5.43
- Period
- 2021
- Total Revenue
- 39.76
- Selling/ General/ Admin Expenses Total
- 3.03
- Depreciation/ Amortization
- 3.28
- Other Operating Expenses Total
- 5.6
- Total Operating Expense
- 36.77
- Operating Income
- 2.99
- Net Income Before Taxes
- -1.1
- Net Income
- -1.1
- Diluted Normalized EPS
- -2.34
- Period
- 2021
- Total Assets
- 35.98
- Total Liabilities
- 31.59
- Total Equity
- 4.39
- Tangible Book Valueper Share Common Eq
- 9.15
- Period
- 2021
- Cashfrom Operating Activities
- 6.53
- Cashfrom Investing Activities
- -0.7
- Cashfrom Financing Activities
- -5.87
- Net Changein Cash
- -0.04
- Period
- 2020
- Total Revenue
- 43.93
- Selling/ General/ Admin Expenses Total
- 3.49
- Depreciation/ Amortization
- 3.41
- Other Operating Expenses Total
- 6.41
- Total Operating Expense
- 40.95
- Operating Income
- 2.98
- Net Income Before Taxes
- -1.55
- Net Income
- -1.57
- Diluted Normalized EPS
- -3.31
- Period
- 2020
- Total Assets
- 38.22
- Total Liabilities
- 44.76
- Total Equity
- -6.54
- Tangible Book Valueper Share Common Eq
- -13.61
- Period
- 2020
- Cashfrom Operating Activities
- 4.83
- Cashfrom Investing Activities
- -0.39
- Cashfrom Financing Activities
- -4.3
- Net Changein Cash
- 0.14
- Period
- 2019
- Total Revenue
- 46.21
- Selling/ General/ Admin Expenses Total
- 3.34
- Depreciation/ Amortization
- 3.53
- Other Operating Expenses Total
- 6.12
- Total Operating Expense
- 38.03
- Operating Income
- 8.18
- Net Income Before Taxes
- 3.57
- Net Income
- 3.56
- Diluted Normalized EPS
- 0.56
- Period
- 2019
- Total Assets
- 39.18
- Total Liabilities
- 44.12
- Total Equity
- -4.94
- Tangible Book Valueper Share Common Eq
- -10.28
- Period
- 2019
- Cashfrom Operating Activities
- 7.85
- Cashfrom Investing Activities
- 3.12
- Cashfrom Financing Activities
- -10.86
- Net Changein Cash
- 0.11
- Period
- 2024-12-31
- Total Revenue
- 10.78
- Selling/ General/ Admin Expenses Total
- 0.84
- Depreciation/ Amortization
- 0.87
- Other Operating Expenses Total
- 2.28
- Total Operating Expense
- 12.41
- Operating Income
- -1.62
- Net Income Before Taxes
- -1.98
- Net Income
- -1.98
- Diluted Normalized EPS
- -3.92
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 10.61
- Selling/ General/ Admin Expenses Total
- 0.81
- Depreciation/ Amortization
- 0.87
- Other Operating Expenses Total
- 2.05
- Total Operating Expense
- 11.42
- Operating Income
- -0.81
- Net Income Before Taxes
- -1.19
- Net Income
- -1.19
- Diluted Normalized EPS
- -2.35
- Period
- 2024-09-30
- Total Assets
- 32.94
- Total Liabilities
- 36.37
- Total Equity
- -3.43
- Tangible Book Valueper Share Common Eq
- -6.84
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 1.08
- Cashfrom Investing Activities
- -0.29
- Cashfrom Financing Activities
- -0.78
- Net Changein Cash
- 0.01
- Period
- 2024-06-30
- Total Revenue
- 10.57
- Selling/ General/ Admin Expenses Total
- 0.85
- Depreciation/ Amortization
- 0.87
- Other Operating Expenses Total
- 2.35
- Total Operating Expense
- 11.44
- Operating Income
- -0.87
- Net Income Before Taxes
- -1.25
- Net Income
- -1.25
- Diluted Normalized EPS
- -2.47
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 11.02
- Selling/ General/ Admin Expenses Total
- 0.84
- Depreciation/ Amortization
- 0.87
- Other Operating Expenses Total
- 2.63
- Total Operating Expense
- 11.66
- Operating Income
- -0.64
- Net Income Before Taxes
- -0.84
- Net Income
- -0.84
- Diluted Normalized EPS
- -1.46
- Period
- 2024-03-31
- Total Assets
- 34.11
- Total Liabilities
- 35.11
- Total Equity
- -1
- Tangible Book Valueper Share Common Eq
- -2.02
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 0.97
- Cashfrom Investing Activities
- -3.69
- Cashfrom Financing Activities
- 1.07
- Net Changein Cash
- -1.66
- Period
- 2023-12-31
- Total Revenue
- 11.3
- Selling/ General/ Admin Expenses Total
- 0.84
- Depreciation/ Amortization
- 0.83
- Other Operating Expenses Total
- 2.59
- Total Operating Expense
- 12.15
- Operating Income
- -0.84
- Net Income Before Taxes
- -1.21
- Net Income
- -1.21
- Diluted Normalized EPS
- -2.52
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
National Oxygen Technical
Moving Average
SMA
- 5 Day103.88
- 10 Day102.08
- 20 Day102.67
- 50 Day106.47
- 100 Day115.4
- 300 Day123.98
National Oxygen Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Super Crop Safe
- 14.65
- -0.25
- -1.68
- 26.44
- 11.7
- 58.91
- Indra Industries
- 10.69
- -0.16
- -1.47
- 20.07
- 5.62
- 57.13
- National Oxygen
- 110.95
- 0.35
- 0.32
- 165
- 94.95
- 56
- The Phosphate Company
- 152.6
- -2.2
- -1.42
- 207.9
- 134.95
- 55.05
- Medi Caps
- 42.75
- -1.54
- -3.48
- 61
- 37.23
- 53.31
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Super Crop Safe
- 45.21
- 2.22
- -5.44
- -4.77
- Indra Industries
- 13.19
- -
- -
- -
- National Oxygen
- -
- -
- -
- 0.42
- The Phosphate Company
- 15.74
- 0.62
- 3.84
- 2.72
- Medi Caps
- -
- 0.44
- 2.8
- 6.1
National Oxygen Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 07-Feb-25
- Quarterly Results
- 11-Nov-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results & A.G.M.
- 22-May-24
- Audited Results
- 02-Mar-24
- Preferential issue of shares
- 13-Feb-24
- Quarterly Results
- 09-Feb-24
- Quarterly Results
- 20-Jan-24
- Preferential issue of shares
- 06-Nov-23
- Quarterly Results
- 11-Aug-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 16-Sept-24
- 26-Aug-24
- AGM
- 20-Feb-24
- 29-Jan-24
- EGM
- 28-Aug-23
- 07-Aug-23
- AGM
- 09-Mar-21
- 05-Feb-21
- POM



